News in the Life Sciences Industry

Novel real world evidence for AFSTYLA® and IDELVION® to be highlighted

LEVERKUSEN, Germany and PHILADELPHIA and TOKYO, July 1, 2019 /PRNewswire/ -- Century Therapeutics, a Versant Ventures-created company developing allogeneic or off-the-shelf immune cell therapies for cancer, emerged from stealth mode today with USD 250 million in financing commitments from Bayer,... Read more ››

SINGAPORE, June 28, 2019 /PRNewswire/ -- The five finalist teams of the inaugural 'Mundipharma Cancer Care Challenge' pitched their ideas on how to harness the power of technology to improve the lives of cancer patients to a panel of judges at Southeast Asia's largest innovation festival, Innovfest... Read more ››

ROME, June 28, 2019 /PRNewswire/ -- Menarini Ricerche today announced the publication of the results of a non-clinical study describing the characterization of the anti-CD205 Antibody-Drug Conjugate (ADC) MEN1309/OBT076. These findings have been published by the journal Molecular Cancer Therapeutics... Read more ››

NORTH CHICAGO, Ill., June 27, 2019 /PRNewswire/ -- AbbVie issued the following forms today.

HUNTSVILLE, Ala., June 27, 2019 /PRNewswire/ -- Discovery Life Sciences(TM) announced today that the company is manufacturing the highest quality fresh, research-grade Discovery Leukopaks for pre-clinical research and offering them at exceptional pricing. Discovery Leukopaks exhibit better than... Read more ››